Facile and One-step Direct Synthesis of Poly(valine) as a Robust Drug Nanocarrier for Enhanced Breast Cancer Therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Facile and One-step Direct Synthesis of Poly(valine) as a Robust Drug Nanocarrier for Enhanced Breast Cancer Therapy
Authors
Keywords
-
Journal
CHINESE JOURNAL OF POLYMER SCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-07
DOI
10.1007/s10118-022-2701-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition
- (2020) Jialong Fan et al. Acta Biomaterialia
- Activated Platelets-Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer
- (2019) Yujie Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
- (2019) Peng Guo et al. Science Advances
- Clinical cancer nanomedicine
- (2019) Joy Wolfram et al. Nano Today
- Pursuing Specific Chemotherapy of Orthotopic Breast Cancer with Lung Metastasis from Docking Nanoparticles Driven by Bioinspired Exosomes
- (2019) Fei Xiong et al. NANO LETTERS
- Nucleus-targeting near-infrared nanoparticles based on TAT peptide-conjugated IR780 for photo-chemotherapy of breast cancer
- (2019) Guoyun Wan et al. CHEMICAL ENGINEERING JOURNAL
- Triple negative breast cancer: A thorough review of biomarkers
- (2019) Jesse Lopes da Silva et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Engineered nanomedicines with enhanced tumor penetration
- (2019) Jianxun Ding et al. Nano Today
- Quantitative Assessment of Nanoparticle Biodistribution by Fluorescence Imaging, Revisited
- (2018) Fanfei Meng et al. ACS Nano
- Light-Activated Core–Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer
- (2018) Qingshuo Meng et al. ACS Nano
- A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity
- (2018) Huicong Zhou et al. Acta Biomaterialia
- Facile synthesis of yolk–shell structured monodisperse mesoporous organosilica nanoparticles by a mild alkalescent etching approach
- (2018) Jun Tao et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Biomacromolecules as carriers in drug delivery and tissue engineering
- (2018) Yujie Zhang et al. Acta Pharmaceutica Sinica B
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- cRGD-installed docetaxel-loaded mertansine prodrug micelles: redox-triggered ratiometric dual drug release and targeted synergistic treatment of B16F10 melanoma
- (2017) Ping Zhong et al. NANOTECHNOLOGY
- Self-assembling dipeptide antibacterial nanostructures with membrane disrupting activity
- (2017) Lee Schnaider et al. Nature Communications
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects
- (2016) Wei Tao et al. Theranostics
- Synthesis of Side-Chain Modified Polypeptides
- (2015) Timothy J. Deming CHEMICAL REVIEWS
- Enzyme-Responsive Release of Doxorubicin from Monodisperse Dipeptide-Based Nanocarriers for Highly Efficient Cancer Treatment In Vitro
- (2014) He Zhang et al. ADVANCED FUNCTIONAL MATERIALS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started